Pharma: Other News To Note
Tuesday, May 1, 2012
Merck & Co. Inc., of Whitehouse Station, N.J., said the District Court for the District of New Jersey ruled in its favor in two jointly related patent infringement suits against Mylan Pharmaceuticals Inc., of Pittsburgh, upholding Merck's patent on Zetia (ezetimibe) and Vytorin (ezetimibe/simvastatin).
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.